L

Early Infant Peanut Introduction Simulator

LEAP Trial Immunological & Epidemiological Model
LEAP Evidence: -77% Risk
Infant Introduction Age 5 Months
0m (Early Window) 6m (Guideline Target) 12m+ (Delayed)
Weekly Peanut Protein Dose 6.0 grams
LEAP Protocol Target: ~6g protein (approx. 3 tsp peanut butter / week)
Infant Eczema / Risk Profile
Micro-Scale Gut Mucosa Cellular Dynamics
Active Tolerization Path
Click / Drag canvas to deposit peanut allergen particles
Treg Cells: 42
IgE Primed / Mast: 4
Naive CD4+: 18
Macro Cohort Epidemic Model (n = 1,000 Infants)
77% Risk Reduction
Early Intro Allergy Rate
3.2%
Delayed Avoidance Rate
17.2%
Relative Risk Drop
-77.2%
LEAP Clinical Evidence & Cohort Outcome Proof
Validated Model
Loading clinical outcome summary...
5 Months
6.0g
32 vs 172 per 1,000
Moderate Eczema

Safe Home Introduction Protocol (NIAID / AAP Guidelines)

1

Ready For Solids (~4-6 Months)

Infant must demonstrate developmental readiness (holding head steady, sitting upright) and have tolerated other solid foods first.

2

Never Whole Peanuts or Chunks

Choking hazard! Dilute 2 teaspoons of smooth peanut butter with 2-3 teaspoons of warm water or breast milk/formula, or mix into fruit puree.

3

Initial First Taste at Home

Offer a small spoon tip when baby is healthy and awake. Wait 10-15 minutes to observe before feeding the remainder of the dose.

4

Sustain Maintenance Dosing

Maintain approximately 6g of peanut protein per week (spread across 2-3 feedings) consistently through early childhood.

Eczema Risk Stratification & Mechanism

High Risk (Severe Eczema)

Infants with severe eczema or egg allergy have disrupted skin barriers. Environmental peanut dust on broken skin drives IgE antibody sensitization (dual-allergen exposure hypothesis). Mandatory medical evaluation / IgE testing prior to introduction.

Moderate Risk (Mild-Moderate Eczema)

The landmark LEAP trial primary focus. Introducing dietary peanut protein early (4-6m) presents the antigen to gut gut-associated lymphoid tissue (GALT), driving CD4+ cells into mucosal regulatory T-cells (Tregs) that suppress allergic responses.

Low Risk (No Eczema)

Introduce freely at home around 6 months in accordance with family dietary preferences and infant readiness.

Enjoy this tool? Build your own with Super